1. Home
  2. ZYXI vs PSF Comparison

ZYXI vs PSF Comparison

Compare ZYXI & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • PSF
  • Stock Information
  • Founded
  • ZYXI 1996
  • PSF 2010
  • Country
  • ZYXI United States
  • PSF United States
  • Employees
  • ZYXI N/A
  • PSF N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PSF Investment Managers
  • Sector
  • ZYXI Health Care
  • PSF Finance
  • Exchange
  • ZYXI Nasdaq
  • PSF Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • PSF 236.8M
  • IPO Year
  • ZYXI N/A
  • PSF N/A
  • Fundamental
  • Price
  • ZYXI $2.62
  • PSF $20.11
  • Analyst Decision
  • ZYXI Buy
  • PSF
  • Analyst Count
  • ZYXI 3
  • PSF 0
  • Target Price
  • ZYXI $6.00
  • PSF N/A
  • AVG Volume (30 Days)
  • ZYXI 291.0K
  • PSF 25.0K
  • Earning Date
  • ZYXI 07-24-2025
  • PSF 01-01-0001
  • Dividend Yield
  • ZYXI N/A
  • PSF 7.69%
  • EPS Growth
  • ZYXI N/A
  • PSF N/A
  • EPS
  • ZYXI N/A
  • PSF N/A
  • Revenue
  • ZYXI $172,401,000.00
  • PSF N/A
  • Revenue This Year
  • ZYXI N/A
  • PSF N/A
  • Revenue Next Year
  • ZYXI $19.55
  • PSF N/A
  • P/E Ratio
  • ZYXI N/A
  • PSF N/A
  • Revenue Growth
  • ZYXI N/A
  • PSF N/A
  • 52 Week Low
  • ZYXI $1.66
  • PSF $16.00
  • 52 Week High
  • ZYXI $10.62
  • PSF $20.19
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 61.26
  • PSF 66.38
  • Support Level
  • ZYXI $2.30
  • PSF $19.64
  • Resistance Level
  • ZYXI $2.58
  • PSF $19.99
  • Average True Range (ATR)
  • ZYXI 0.16
  • PSF 0.11
  • MACD
  • ZYXI 0.05
  • PSF 0.01
  • Stochastic Oscillator
  • ZYXI 96.98
  • PSF 83.71

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About PSF Cohen & Steers Select Preferred and Income Fund Inc.

Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.

Share on Social Networks: